Atlas Trials

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

Clinical trial NCT02214602 · COMPLETED

Trial details

NCT number
NCT02214602
Sponsor
Mansoura University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Carcinoma of Urinary Bladder, Superficial
Start date
2014-07-01
Primary completion
2017-04-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.